Bruker Corporation (NASDAQ:BRKR) has a beta value of 1.27 and has seen 0.44 million shares traded in the last trading session. The company, currently valued at $13.71B, closed the last trade at $91.36 per share which meant it gained $0.56 on the day or 0.62% during that session. The BRKR stock price is 0.53% off its 52-week high price of $90.88 and 59.21% above the 52-week low of $37.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.46 million shares traded. The 3-month trading volume is 715.35K shares.
The consensus among analysts is that Bruker Corporation (BRKR) is a Hold stock at the moment, with a recommendation rating of 2.30. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 7 out of 12 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is $0.38.
Bruker Corporation (NASDAQ:BRKR) trade information
Sporting 0.62% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the BRKR stock price touched $91.36 or saw a rise of 0.75%. Year-to-date, Bruker Corporation shares have moved 68.78%, while the 5-day performance has seen it change 3.79%. Over the past 30 days, the shares of Bruker Corporation (NASDAQ:BRKR) have changed 12.35%. Short interest in the company has seen 1.54 million shares shorted with days to cover at 2.68.
Wall Street analysts have a consensus price target for the stock at $82.75, which means that the shares’ value could drop -10.4% from current levels. The projected low price target is $68.00 while the price target rests at a high of $95.00. In that case, then, we find that the current price level is -3.98% off the targeted high while a plunge would see the stock lose 25.57% from current levels.
Bruker Corporation (BRKR) estimates and forecasts
Figures show that Bruker Corporation shares have outperformed across the wider relevant industry. The company’s shares have gained 55.59% over the past 6 months, with this year growth rate of 42.22%, compared to 26.80% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 81.00% and 4.80% for the next quarter. Revenue growth from the last financial year stood is estimated to be 19.10%.
10 analysts offering their estimates for the company have set an average revenue estimate of $538.71 million for the current quarter. 11 have an estimated revenue figure of $575.38 million for the next quarter concluding in Sep 2021. Year-ago sales stood $424.6 million and $511.4 million respectively for this quarter and the next, and analysts expect sales will grow by 26.90% for the current quarter and 12.50% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 11.20% over the past 5 years. Earnings growth for 2021 is a modest -18.90% while over the next 5 years, the company’s earnings are expected to increase by 16.50%.
Bruker Corporation is expected to release its next earnings report between November 01 and November 05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.16 at a share yield of 0.18%. The company’s dividend yield has gone up over the past 12 months.
Bruker Corporation (NASDAQ:BRKR)’s Major holders
Insiders own 32.78% of the company shares, while shares held by institutions stand at 70.66% with a share float percentage of 105.12%. Investors are also buoyed by the number of investors in a company, with Bruker Corporation having a total of 401 institutions that hold shares in the company. The top two institutional holders are Price (T.Rowe) Associates Inc with over 24.88 million shares worth more than $1.89 billion. As of Jun 29, 2021, Price (T.Rowe) Associates Inc held 16.48% of shares outstanding.
The other major institutional holder is FMR, LLC, with the holding of over 20.18 million shares as of Jun 29, 2021. The firm’s total holdings are worth over $1.53 billion and represent 13.36% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Price (T.Rowe) Mid Cap Growth Fund and Fidelity Select Portfolios – Medical Technology & Devices Port. As of Mar 30, 2021, the former fund manager holds about 6.42% shares in the company for having 9.7 million shares of worth $623.52 million while later fund manager owns 3.08 million shares of worth $234.02 million as of Jun 29, 2021, which makes it owner of about 2.04% of company’s outstanding stock.